Vera Therapeutics, Inc. (VERA) Discusses Accelerated FDA Approval of TRUTAKNA for IgA Nephropathy Transcript

Discusses Accelerated FDA Approval of TRUTAKNA for IgA Nephropathy July 7, 2026 4:30 PM EDTCompany ParticipantsSean Grant ...
The Lancet

[177 Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial

Lu]Lu-edotreotide led to statistically significant and clinically meaningful improvements in progression-free survival.
verywellhealth

Why a Doctor’s Office Isn’t Always an Ideal Place to Measure Blood Pressure—And What to Do

Josephine Hessert, DO, is a board-certified emergency medicine physician based in Southern California. Blood pressure readings at a medical office may be inaccurate or misleading due to measurement ...